Javascript er ikke aktivert i din nettleser. Dette er nødvendig for å bruke Oncolex. Kontakt din systemadministrator for å aktivere JavaScript.

Prognosis of non-Hodgkin lymphoma

For non-Hodgkin lymphoma, 27.6% are diagnosed at the local stage and the 5-year survival for localized non-Hodgkin lymphoma is 82.9%. The number of non-Hodgkin lymphoma deaths is highest among people aged 75-84. Death rates have been falling on average 2.3% each year over 2005-2014.

In the United States, the 5-year relative survival rate of patients with non-Hodgkin lymphoma during the diagnosis period 2007-2013, was 71%.

In 2014, there were an estimated 661,996 people living with non-Hodgkin lymphoma in the United States.

Oslo University Hospital shall not be liable for any loss whether direct, indirect, incidental or consequential, arising out of access to, use of, or reliance upon any of the content on this website. Oslo University Hospital© 2018